Symbiotec Pharmalab Reports Q2FY27 Revenue Surge and Profit Expansion
Symbiotec Pharmalab Ltd 路 Press Release 路 06 Nov 2026, 1:53 am
Symbiotec Pharmalab Reports Q2FY27 Revenue Surge and Profit Expansion Symbiotec Pharmalab delivered strong Q2FY27 results, with consolidated revenue rising 43% YoY to Rs. 280 crs, EBITDA up 88% YoY to Rs. 94 crs, and PAT jumping 169% YoY to Rs. 52 crs. Growth was aided by Rs. 53 crs in milestone revenue from Complex Injectables alongside steady 16% YoY growth in API revenue to Rs. 227 crs. For H1FY27, revenue reached Rs. 498 crs (up 25% YoY) with PAT at Rs. 66 crs. Net debt stood at ~Rs. 314 crs as of 30th Sep'26.
Original exchange filing (PDF)
More announcements from Symbiotec Pharmalab Ltd
- Intimation regarding change in Corporate Identification Number (CIN) and Listing Status of the Company. 路 17 Nov 2026
- Transcript of the Earnings conference call for the Analysts and Investors for the Quarter and Half year ended 路 12 Nov 2026
- Pursuant to Regulation 30(6) read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, as amended from time .... 路 12 Nov 2026
- Pursuant to Part A of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Audio recording of Conference Call for Analysts and Investors held on November .... 路 06 Nov 2026
- Symbiotec Signs 10 Year take or Pay Agreement to Manufacture Fermentation based alternative protein for EU Innovator 路 06 Nov 2026
- The Monitoring Agency report issued by the CARE Edge Ratings, Monitoring Agency, appointed by the Company for the utilisation and application of funds raised through the IPO of the Company .... 路 06 Nov 2026
- Pursuant to regulations 30 of the SEBI Listing Regulations, Investor Presentation on the Unaudited Standalone and Consolidated Financial Results for the Quarter and Half Year ended September 30, 2026. 路 06 Nov 2026
- Symbiotec Pharmalab Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 06 Nov 2026
